CINGNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CINGW
Cingulate Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$4.36+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $57.49M
- P/E (TTM)
- –
- Dividend yield
- –
Cingulate statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Cingulate | Industry median |
|---|---|---|
| Market Cap | $63.40M | $166.30M |
| Enterprise Value | $35.00M | $88.19M |
| PB Ratio | 2.70 | 2.03 |
| P/TBV Ratio | 2.70 | 2.29 |
Income (trailing twelve months)
| Measure | Cingulate | Industry median |
|---|---|---|
| Operating Income | -$24.92M | -$21.40M |
| Pretax Income | -$28.80M | -$14.34M |
| Net Income | -$28.80M | -$22.46M |
| EBITDA | -$24.92M | -$16.91M |
| EPS (Diluted) | -$3.68 | -$0.83 |
Returns
| Measure | Cingulate | Industry median |
|---|---|---|
| Return on Equity (ROE) | -198.7% | -53.2% |
| Return on Assets (ROA) | -123.8% | -40.9% |
| Return on Capital Employed (ROCE) | -102.0% | -38.1% |
Balance sheet
| Measure | Cingulate | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $28.40M | $61.43M |
| Net Cash (Debt) | $28.40M | $15.35M |
| Net Cash Per Share | $1.95 | $0.66 |
| Equity (Book Value) | $23.47M | $49.09M |
| Book Value Per Share | $1.61 | $1.37 |
| Tangible Book Value | $23.47M | $23.52M |
| Working Capital | $21.58M | $76.81M |
Financial position
| Measure | Cingulate | Industry median |
|---|---|---|
| Current Ratio | 3.50 | 3.34 |
| Quick Ratio | 3.29 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Cingulate | Industry median |
|---|---|---|
| Operating Cash Flow | -$20.65M | -$12.35M |
| Capital Expenditures | -$284.48K | -$1.08M |
| Free Cash Flow | -$20.94M | -$20.22M |
| FCF Per Share | -$1.44 | -$0.42 |
Efficiency
| Measure | Cingulate | Industry median |
|---|---|---|
| Profits Per Employee | -$57.59K | -$703.34K |
| Employee Count | 500 | 74 |
Dividends and yields
| Measure | Cingulate | Industry median |
|---|---|---|
| Earnings Yield | -45.4% | -23.3% |
| FCF Yield | -33.0% | -8.72% |
| Buyback Yield | -55.4% | -0.59% |
| Shareholder Yield | -55.4% | 0.00% |
Shares
| Measure | Cingulate | Industry median |
|---|---|---|
| Shares Outstanding | 14,541,800 | 58,127,000 |
| Shares Change (QoQ) | 16.7% | 0.54% |
| Float | 10,404,900 | 49,136,700 |
| Shares Held by Insiders | 28.4% | 11.6% |
| Shares Held by Institutions | 13.4% | 59.4% |
Scores
| Measure | Cingulate | Industry median |
|---|---|---|
| Altman Z-Score | -3.99 | -0.22 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Cingulate's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.